New trial aims to find best COVID-19 antivirals

NCT ID NCT05041907

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 30, 2026 · Updated 21 times

Summary

This study tests different COVID-19 treatments, including pills and antibodies, in adults with mild symptoms. Participants are healthy volunteers aged 18-60 who test positive for COVID-19. The main goal is to see how quickly each treatment clears the virus from the body compared to no treatment or the best available option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bangplee Hospital
TERMINATED

Mueang Samut Prakan, 10540, Thailand
Faculty of Tropical Medicine, Mahidol University
RECRUITING

Bangkok, 10400, Thailand

Contact Email: •••••@•••••
Laos-Oxford-Mahosot Wellcome Trust Research Unit
RECRUITING

Vientiane, 01000, Laos

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sukraraj Tropical & Infectious Disease Hospital
RECRUITING

Kathmandu, Nepal

Contact Email: •••••@•••••
The Aga Khan University Hospital
TERMINATED

Karachi, Pakistan
Universidade Federal de Minas Gerais
RECRUITING

Minas Gerais, Brazil

Contact Email: •••••@•••••
Vajira hospital
TERMINATED

Bangkok, 10300, Thailand

Conditions

Explore the condition pages connected to this study.

COVID-19